According to Morphic Holding, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:16 PM, company Chief Scientific Officer, Rogers Bruce disclosed selling 4,654 shares at a cost of $40.03. At the time of this transaction (Feb 08), this trade was worth $186,280 in total. […]
According to Hca Healthcare, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:14 PM, company Group President, Foster Jon M disclosed selling 6,171 shares at a cost of $176.44. At the time of this transaction (Feb 08), this trade was worth $1,088,811 in total. […]
According to Federal Agricultural Mortgage Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:08 PM, company 10% Owner, Zions Bancorporation, National disclosed selling 10,000 shares at a cost of $82.36. At the time of this transaction (Feb 09), this trade was worth $823,583 in […]
According to Federal Agricultural Mortgage Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:08 PM, company 10% Owner, Zions Bancorporation, National disclosed selling 10,000 shares at a cost of $82.27. At the time of this transaction (Feb 08), this trade was worth $822,700 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 1,137 shares at a cost of $23.07. At the time of this transaction (Feb 10), this trade was worth $26,231 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 1,600 shares at a cost of $23.06. At the time of this transaction (Feb 10), this trade was worth $36,896 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 23,569 shares at a cost of $23.08. At the time of this transaction (Feb 09), this trade was worth $543,973 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 20,401 shares at a cost of $23.04. At the time of this transaction (Feb 09), this trade was worth $470,039 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 4,528 shares at a cost of $23.00. At the time of this transaction (Feb 08), this trade was worth $104,144 in […]
According to Kiniksa Pharmaceuticals, Ltd.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company Chairman & CEO, Patel Sanj K disclosed selling 4,924 shares at a cost of $23.00. At the time of this transaction (Feb 08), this trade was worth $113,252 in […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
